NATURE’S SUNSHINE PRODUCTS, INC.

NATR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-13.8M $675.0K $13.7M $9.8M $17.6M $25.4M $17.6M $-1.2M
Depreciation & Amortization $8.6M $4.8M $4.5M $4.4M $4.5M $4.1M $4.4M $4.3M
Depreciation $8.5M $4.7M $4.4M $4.3M $4.3M $3.9M $4.2M $4.1M
Amortization $200.0K $100.0K $100.0K $100.0K
Stock-Based Compensation $2.2M $3.2M $4.5M $3.9M $3.4M $2.9M $3.5M $437.0K
Net Cash from Operating Activities $10.5M $3.4M $10.2M $14.2M $29.4M $26.7M $3.9M $16.2M
Investing Activities
Capital Expenditures $5.5M $11.0M $22.5M $26.3M $8.6M $6.6M $2.4M $2.6M
Business Acquisitions
Net Cash from Investing Activities $-3.2M $-11.5M $-18.6M $-26.7M $-8.6M $-3.0M $-1.7M $-5.9M
Financing Activities
Dividends Paid $1.8M $7.5M $7.5M $35.2M $30.4M $2.3M
Stock Repurchases $0 $0 $6.6M $7.5M $2.5M
Net Cash from Financing Activities $1.6M $-286.0K $-7.6M $-5.1M $-21.3M $-3.1M $9.6M $132.0K
Net Change in Cash $10.6M $-9.1M $-17.3M $-18.5M $-2.0M $20.3M $11.4M $12.1M
Free Cash Flow $5.0M $-7.6M $-12.4M $-12.1M $20.8M $20.0M $1.5M $13.6M
← Newer Page 2 of 3 Older →